42 34
30
18
32
34
36 Cover Story 14 The cover story entitled “Electrophoresis Equipment and Supplies Market expected to expand at a CAGR of 4.5% by 2027” a market research on Electrophoresis equipment. According to a recent market report published by FMI titled ‘Electrophoresis Equipment and Supplies Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2027,’ the global Electrophoresis Equipment and Supplies market was valued at US$ 1,854.8 Mn in 2017, and is expected to register a CAGR of 4.5% from 2018 to 2027.
Featured article 16 Added to this, the current edition has a special featured guest article entitled “3D MicroPrint use the FT4 Powder Rheometer to push AM to its limits” by Freeman Technology a Micromeritics company.
Product Launches 30 The edition also covers recent Pharma news articles and product launches collected from worldwide sources to update the readers with the current trends in the industry
3D MicroPrint use the FT4 Powder Rheometer to push AM to its limits
16
3D MicroPrint GmbH (Chemnitz, Germany), a company pioneering the use of Additive Manufacturing (AM) to produce complex, micro-scale metal parts, is using the FT4 Powder Rheometer® from Freeman Technology (Tewkesbury, UK) to identify ultra-fine powders that will process efficiently.
India’s Biggest Pharma Expo in the National Capital
20
“Indian Pharma Expo 2019” is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi.IPE 2019 will provide an opportunity for the participating companies to display their products & services to the gamut of business visitors, globally from Pharma and healthcare industries.
Telstar launches a new website and consolidates its digital communication strategy
25
Terrassa (Barcelona) 2019 May 13th. Telstar has renewed the design and architecture of its website. With a web-portal adapted to an operational and practical format, the new website consolidates the company’s strategy in the field of digital communication.
Microbioz India, June 2019
09
ear friends and readers, I hope you would have enjoyed reading our previous issue. Once again, I am delighted to bring to you the June 2019 edition of Microbioz India magazine, supported by the cover story entitled “Electrophoresis Equipment and Supplies Market expected to expand at a CAGR of 4.5% by 2027 ” a market research on Electrophoresis equipment. According to a recent market report published by FMI titled ‘Electrophoresis Equipment and Supplies Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2027,’ the global Electrophoresis Equipment and Supplies market was valued at US$ 1,854.8 Mn in 2017, and is expected to register a CAGR of 4.5% from 2018 to 2027. Added to this, the current edition has a special featured guest article entitled “3D MicroPrint use the FT4 Powder Rheometer to push AM to its limits” by Freeman Technology a Micromeritics company. 3D MicroPrint GmbH (Chemnitz, Germany), a company pioneering the use of Additive Manufacturing (AM) to produce complex, micro-scale metal parts, is using the FT4 Powder Rheometer® from Freeman Technology (Tewkesbury, UK) to identify ultra-fine powders that will process efficiently. The company works with powders less than five microns in size to deliver components with cutting edge accuracy and resolution. The FT4 Powder Rheometer differentiates raw materials that exhibit the superior flow characteristics required for successful use of 3D MicroPrint’s Micro Laser Sintering (MLS) technology, for applications in the medical, semiconductor, aerospace, energy and chemical industries. We have the latest market research news and insightful product launches inside, collected from worldwide sources to keep you updated with what is going on in the industry. Dear friends and readers, I hope you find some value in the magazine. Also, I would like to thanks you for being together in this beautiful journey so far. We would love to have your valuable feedback and suggestions as they help us to come up with better content each time. For any further valuable addition, please write to us at editor@microbiozindia.com.
DISCLAIMER: This disclaimer informs readers that the views, thoughts, and opinions expressed in the Articles, Advertisements published in the magaizne belong solely to the author, advertisers and not necessarily to the author’s employer, organization, committee or other group or individual. The published material, adverts, editorials and all other content is published in a Microbioz India magazine cannot guarantee and accepts no liability for any loss or damage of any kind caused by this magazine and errors and for the accuracy of claims made by the advertisers.
Cover Story
Electrophoresis Equipment and Supplies Market expected to expand at a CAGR of 4.5% by 2027 ccording to a recent market report published by FMI titled ‘Electrophoresis Equipment and Supplies Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2027,’ the global Electrophoresis Equipment and Supplies market was valued at US$ 1,854.8 Mn in 2017, and is expected to register a CAGR of 4.5% from 2018 to 2027.
A
Increasing Application of Capillary Electrophoresis in Microbial Detection Driving Electrophoresis Equipment and Supplies Market Growth The global electrophoresis equipment and supplies market is categorised on the basis of type, application, end user and region. On the basis of type, the electrophoresis equipment and supplies market is segmented into capillary electrophoresis, gel electrophoresis and other accessories. Among the types segments, the capillary electrophoresis equipment and supplies segment is expected to grow at higher CAGR as compared to gel electrophoresis due to the increasing preference for capillary electrophoresis equipment and supplies. Increase in the number of research activities in biochemistry and medical research projects are some of the prime factors responsible for the growth of the electrophoresis equipment and supplies market at the global level. Increasing complexities in the treatment of diseases, such as cancer, genetic transmitted diseases and other health issues, is also one of the factors fuelling the growth of the electrophoresis equipment and supplies market. The application of capillary electrophoresis equipment and supplies in areas, such as microbial detection and protein analysis, is boosting the popularity of capillary electrophoresis equipment and supplies. The recent boom in biological research activities in different areas, such as research and academic institutes, hospitals and others, for performing DNA analysis, sequencing and other processes is boosting the demand for electrophoresis equipment and supplies globally. Moreover, rapid increase in competition among pharmaceutical
and biotechnology companies is boosting the need for the deployment of efficient and automatic equipment such as electrophoresis equipment and supplies. These industry verticals are using electrophoresis equipment and supplies for drug discovery, antibody research and others considering that the applications of electrophoresis equipment and supplies are expected to increase significantly over the forecast period. On the basis of applications, the electrophoresis equipment and supplies market is segmented into diagnostics (proteins), haemoglobin and microbial detection. Due to increase in the transmission of infectious diseases, the need for finding out suitable solutions is rising, owing to which the adoption of electrophoresis equipment and supplies is also increasing rapidly. Considering the increasing need for carrying out different studies, the electrophoresis equipment and supplies market is expected to increase significantly over the forecast period. On the basis of equipment type, the electrophoresis equipment and supplies market is segmented considering the categories in which electrophoresis equipment and supplies are available as well as their application areas. Based on type, the electrophoresis equipment and supplies market is segmented into gel electrophoresis, capillary electrophoresis and accessories. The revenue contribution from the capillary electrophoresis segment is expected to expand at a CAGR of 5.8% during the forecast period in the global electrophoresis equipment and supplies market. Capillary electrophoresis are widely preferred as they are easy to operate and provide accuracy, thus contributing to the growth of the electrophoresis equipment and supplies market.
Increasing Application in Studying DNA Sequencing and Molecular Level Identification to Boost Electrophoresis Equipment and Supplies Market Growth On the basis of end use, the electrophoresis equipment and supplies market is segmented into hospitals & diagnostics centres, academic & research institutes, biotechnology & pharmaceutical companies and others. Due to
Microbioz India, June 2019
14
Cover Story constant investments in conducting research for studying the biological properties and molecular identification, the demand from the academic & research institutes for electrophoresis equipment and supplies is expected to grow significantly. In addition, biotechnology & pharmaceutical companies are focusing on modifying the properties of their products for which the number of DNA-level studies is increasing rapidly, which is significantly fuelling the demand for electrophoresis equipment and supplies.
supplies to increase revenue, which is likely to enable the vendors of electrophoresis equipment and supplies to reach new growth markets. In addition, Thermo Fisher Scientific is one of the prominent vendors in the electrophoresis equipment and supplies market. The company is offering electrophoresis equipment and supplies for different end users such as hospitals & diagnostics centres, academic & research institutes, pharmaceutical & biotechnology companies and others. As per FMI analysis, Thermo Fisher Scientific is expected to dominate Regional Overview: North America to the global electrophoresis equipment and supplies Dominate the Global Market market as the company is focusing on launching The electrophoresis equipment and supplies new products and report also covers upgrading its the trends that The global electrophoresis existing products to drive each segment, enhance its user equipment and supplies as well as offers experience and analysis & insights market is categorised on the customer base. regarding the growth potential of basis of type, application, end Some of the market participants featured the market in user and region. in the global regions such as electrophoresis North America (U.S. & Canada), Latin America equipment and supplies market report are Bio-Rad (Brazil, Mexico & the rest of Latin America), Laboratories; GE Healthcare; Harvard Bioscience, Europe (Germany, Italy, France, Russia, U.K. & Inc.; Sebia Group; ThermoFisher Scientific Inc.; the rest of Europe), Japan, APEJ (China, India, Danaher Corporation; Agilent Technologies; Malaysia, Australia, Singapore & the rest of APEJ) Hoefer Inc.; Merck Millipore; PerkinElmer, Inc.; and MEA (GCC Countries, Israel, South Africa & QIAGEN N.V.; Labnet International, Inc.; Lonza the rest of MEA). The widespread presence of Group Ltd.; Lumex Instruments; Shimadzu biotechnology and pharmaceutical companies due Corporation and others. These players are to increasing research and development activities focusing on entering the electrophoresis in North America is one of the prime factors equipment and supplies market in new areas of boosting the North America electrophoresis developing regions. equipment and supplies market. This region is For more information ask for sample report @ expected to dominate the global electrophoresis https://www.futuremarketinsights.com/repo equipment and supplies market over the forecast rts/sample/REP-GB-237 period. APEJ region is estimated to grow with a About us: CAGR of 6.5% over the forecast period owing to Future Market Insights (FMI) is a leading market rapid industrialisation, which has created the need intelligence and consulting firm. We deliver for electrophoresis equipment and supplies in this syndicated research reports, custom research region. Furthermore, the demand for reports and consulting services, which are electrophoresis equipment and supplies in personalized in nature. FMI delivers a complete developing countries is increasing due to the packaged solution, which combines current penetration of international brands in this region, market intelligence, statistical anecdotes, which has created the demand for devices such as technology inputs, valuable growth insights, an electrophoresis equipment and supplies to deliver aerial view of the competitive framework, and quality products. future market trends. Electrophoresis Equipment and Supplies Market: Competitive Landscape Contact: Future Market Insights According to FMI analysis, acquisitions, 616 Corporate Ways, Suite 2-9018, improvement in the durability of products and Valley Cottage, NY 10989, improvements in the network of distributors are United States T: +1-347-918-3531 some of the key strategies adopted by the F: +1-845-579-5705 manufacturers of electrophoresis equipment and Email: sales@futuremarketinsights.com supplies. These strategies are expected to help the Website:www.futuremarketinsights.com manufacturers of electrophoresis equipment and Microbioz India, June 2019
15
Guest Post
3D MicroPrint use the FT4 Powder Rheometer to push AM to its limits 3D MicroPrint GmbH (Chemnitz, Germany), a company pioneering the use of Additive Manufacturing (AM) to produce complex, microscale metal parts, is using the FT4 Powder Rheometer® from Freeman Technology (Tewkesbury, UK) to identify ultra-fine powders that will process efficiently. The company works with powders less than five microns in size to deliver components with cutting edge accuracy and resolution. The FT4 Powder Rheometer differentiatesraw materials that exhibit the superior flow characteristics required forsuccessful use of 3D MicroPrint’s Micro Laser Sintering (MLS) technology, for applications in the medical, semiconductor, aerospace, energy and chemical industries. ‘With MLS we are essentially pushing standard AM towards its performance limits,’ said Joachim Goebner, CEO at3D MicroPrint. ‘To achieve precise control at the micro scale we spread powders in layers just a few microns thick before selectively fusing areas of the powder bed with a highly focused laser beam. The ultra-fine powders required typically behave quite differently to powders of > 25µm particle size. We therefore rely on the FT4 Powder Rheometer to identify materials which will performeffectively with our machines, with specified process parameters. Before we had the instrument selecting a suitable powder was essentially a matter of trial and error, a far less efficient approach.’ MLS is a highly specialised form of Selective Laser Sintering with the capability to cost-effectively produce highly complex and bespoke micro size designs. In addition to supplying machines and powders for MLS, 3D MicroPrintruns a job shop to manufacture components and offers expert support for those looking to adopt the technology. The powder materials used, includingtitanium, stainless-steel and others, are all specified in terms of chemical purity, particle size distribution and particle shape. The FT4 Powder Rheometer enables the complementary measurement of dynamic flow properties which have been shown to correlate well with performance in AM processes.
‘All AM processes require powders with optimised properties, and MLS is particularly exacting because of the powders used and the depth of layers required,’ said Goebner. ‘Exemplary powder handling skills underpin our success and the FT4 Powder Rheometer is essential in this regard. By providing sensitive, accurate, highly relevant data the instrument directly supports all our activities, increasing the efficiency with which we apply MLS technology to meet customer requirements’. For more information about Freeman Technology, please go to www.freemantech.co.uk. For more information about 3D MicroPrint, please go to www.3dmicroprint.com. For more details in India: rajiv@apexchromatography.com
Image Caption: FT4 Powder Rheometer
Image Caption: 3D MicroPrint – Additive Manufacturing Powder Samples
Image Caption: 3D MicroPrint – Micro Laser Sintering Machines
Microbioz India, June 2019
16
Business News
Thermo Fisher Scientific Inaugurates New World-Class Facility for Packaging and Distribution to Accelerate Clinical Trials Services in India
Ahmedabad, India – (21 May 2019) – Thermo Fisher Scientific Inc. today announced the opening of a state-of-the-art packaging and distribution facility in Ahmedabad to better serve pharmaceutical customer growth in India and their increasing need for clinical trial support focused on local products for India’s market. The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built to help address the growing demand for development supply chain services and the need for high quality primary and secondary packaging solutions. The facility is spread across 26,700 square feet and equipped with advanced systems to manage all aspects of product control, product flow and quality assurance. The new capabilities also include
blistering, bottle filling, capsule filling, over encapsulation, walleting, blinding solutions for biologics in several delivery modes such as prefilled syringes, and vials. In addition, the facility will cater to regulatory-compliant labelling solutions including JIT labeling, single panel, multi-panel and booklet labels, and capabilities in distribution and logistics management at several controlled temperatures such as ambient, 2 – 8 degree Celsius and frozen conditions. With proficiency in comparator sourcing, clinical ancillary, distribution and logistics management, including returns and destruction of highly regulated pharmaceuticals samples to patients participating in clinical trials, Thermo Fisher’s clinical trial business is a leading single source solution provider. Microbioz India, June 2019
18
Business News “Our customers are looking to outsource their clinical trials management to partners who are well equipped to operate within the changing global and regional clinical trials regulations. With the added capacity available to us with this new facility, we can bring a higher level of technology, quality and expertise to facilitate clinical trials that serve the needs of both multi-national and local pharmaceutical companies in the country,” said Amit Chopra, managing director, India and Middle East, Thermo Fisher Scientific. "This opening represents our commitment to making continuous investments in our sites to ensure we can offer the most innovative and stateof-the-art services in the clinical trial space,” said Leon Wyszkowski, president, Clinical Trials, Thermo Fisher. “This new facility will help us meet the unique needs of local innovators and enable them to bring impactful therapies to market.” With many major pharmaceutical companies setting up their base in India, the clinical trials industry is witnessing considerable growth and India has the potential to become one of the largest clinical trial hubs with an expected market growth of CAGR 12 percent. This announcement follows the recent news of an agreement to acquire and API manufacturing
facility in Cork, Ireland, from GlaxoSmithKline, and the completion acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies. Thermo Fisher is also investing $150 million to expand its sterile fill sites in Monza and Ferentino, Italy, and Greenville, North Carolina and plans to complete the previously announced $50 million expansion of its St. Louis, Missouri, biologics facility later this year. About Thermo Fisher Scientific: Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.
Pre Event
India’s Biggest Pharma Expo in the National Capital “Indian Pharma Expo 2019” is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi. New Delhi: India’s famous Pharma event “Indian Pharma Expo 2019” will be inaugurated on 16th July at HALL No. 12A, Pragati Maidan, New Delhi. At the time of inauguration Key dignitaries from Department of Pharmaceuticals, Ministry of Chemical and Fertilizers, Ministry of MSME, Govt. of India and Dr. Monica Bhatia, MD CIMS Medica will be present. About Show – IPE 2019 will provide an opportunity for the participating companies to display their products & services to the gamut of business visitors, globally from Pharma and healthcare industries. In its 8th edition of IPE 2019, more than 100 companies are participating from all over India and abroad to display their products, innovative technologies and new trends which will be coming soon in the future of the Indian Pharmaceutical market. Key pharmaceutical manufacturing companies, additives/APIs suppliers, ayurvedic and herbal product manufacturers, Pharma Machinery Solution providers, CROs, infrastructure solution providers and many other pharmaceutical companies will be exhibiting in this expo. The expo is expected to witness the international and national visitor footfalls of approximately 10,000. Along with the expo IPE also presents ‘Business Excellence Awards to felicitate the achievers in pharmaceutical industry in various domains to encourage healthy competition which will result into better delivery of pharmaceutical services.
According to Make in India Report, India will be 3rd largest pharmaceuticals market by 2020 and USD 45 Billion in revenue by 2020. India is expected to rank amongst the top three pharmaceutical markets in terms of incremental
growth by 2020. India is the sixth largest market globally in terms of size. Dr.Monica Bhatia addressed about The Indian government steps to reduce costs and bring down healthcare expenses quoting “The introduction of generic medicines into the market might benefit Indian pharmaceutical companies. The thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies. The Government of India has also unveiled “Pharma Vision 2020” whose main objective is to make India one of the world's leading destinations for end-to-end drug discovery and innovation by 2020. In order to boost investments in pharmaceutical market, the Government has reduced the approval time for new facilities”. At IPE 2019 key issues from Pharma industry will be addressed related to Finance, Govt. policies, Expansion, Export and success stories of some biggest pharma giants.
Microbioz India, June 2019
20
Pre Event
PharmaLytica 2019 set for an impressive debut in Mumbai Over 300 turnkey exhibitors to participate in India’s most comprehensive Analytical, Lab, Pharma Machinery & Ingredients Trade Show Mumbai, 2 June, 2019: UBM India, organizers of CPhI / P-MEC India, the leading global pharma trade show and conference, today announced that the 6th edition of the PharmaLytica expo will move to Mumbai from Hyderabad. Formerly a two day event, Pharmalytica 2019 will be an even more comprehensive three day show slated to be held between June10-12, 2019 at the Bombay Exhibition Center, Mumbai. The reputed pharma related expo will seek to leverage the opportunities provided by the impressive pharma hub in West India, while also being in close proximity to the South Indian market. The expo will enable the pharmaceutical community pick up on the latest industry trends, innovations and conduct business with Analytical, Laboratory, Machinery, Packaging, Pharma ingredients and other allied Industries. The expo is well supported by associations including Pharmexcil, Confederation of Indian Pharmaceutical Industry (CiPi) and Indian Drug Manufacturers’ Association ( IDMA ). In the current edition, PharmaLytica will witness the participation of over 300 exhibitors from across the country including notable industry players, many of whom are making their maiden showcasing at Pharmalytica. Some of the exhibitors include Elmach Packages, Shimadzu, Dockweiler AG, Micronclean, Rotarex, Bruker India Scientific, Sartorius, Schott Kaisha, Gattefosse, Perkin Elmer; Thermolab Scientific Equipments, Nicomac Cleanrooms, Mack Pharmatech, Gangwal Chemicals; Kirloskar Pneumatic, Swati Spentose, Borosil Glass Works, Accupack Engineering, NPM Machinery, Toshvin Analytical, Spinco Biotech, Scientific Research Instruments, LP Global, Bitzer India and Anton Paar among others.
With country participation from Luxembourg, United Kingdom, Germany and China, as well as state presence from Maharashtra, Gujarat, Andhra Pradesh, Telangana, Punjab, Haryana, Tamil Nadu, Delhi and Uttarakand, PharmaLytica is well on its way to becoming a truly pan-India congregation that reaches out to all major Industry sectors and Pharma Hubs. This year, there will be special pavilions dedicated to Pharma Machinery & Packaging; Lab Analytical & Cleanroom and API’s & Excipients Pavilion.To enhance the touch-and-feel aspect of the expo, one of the much-anticipated highlights will be the inclusion of Exhibitor Showcase, where visitors can attend featured presentations, hear best of case studies around innovations and technologies trending within the Pharma marketplace. Exclusive B2B Meeting Area and Customer Insight Lounge will also be organised to connect buyers and sellers, enhance the ease of doing business as well as to increase sectoral insights. Among other notable showcases, India’s top academic institution IIT Powai, Mumbai will exhibit its State of Art Analytical Lab - the Sophisticated Analytical Instrument Facility (SAIF). The facilitywas originally established at the Indian Institute of Technology, Bombay, in the year 1976, with the support of the Department of Science & Technology, Government of India, New Delhi. Speaking on the announcement of the 6th edition of PharmaLytica, Mr. Yogesh Mudras, Managing Director, UBM India said,“Over the years, PharmaLytica has evolved as the leading marketplace for products and services along the entire value chain in niche segments within the Pharma industry. This year, we are delighted to move the expo to Mumbai to leverage the proliferating pharma hub of West India in addition to the Southern market. Meanwhile, with our rich legacy of knowledge sharing in the South, I am also pleased to announce the separate launch of PharmaLytica Confex on August 8-9 in Hyderabad. Cumulatively, the PharmaLytica brand seeks to deepen understanding of the changing landscape in the sector to enable strategically sound responses to marketplace trends. It will also play a key role in establishing a unique drug safety ecosystem in India”. “By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and the 6th largest market globally in absolute size. The pharma companies are
Microbioz India, June 2019
22
Pre Event making tremendous efforts to discover new drugs, increasing R&D expenditure, implementing technology and introducing new methodologies to improve quality of manufacturing. Our focus at PharmaLytica, would be to keep the companies abreast with innovations in the growing businesses of India’s pharma industry,” he further added. India enjoys an important position in the global pharmaceuticals sector and the largest provider of generic drugs globally. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in FY18 and have reached US$ 15.52 billion in FY19 (up to January 2019). The various economic drivers and government policies like pharma parks, allowing 100 per cent FDI, boosting the biosimilars and biologics sector, along with ancillary sectors, and reducing manufacturing costs are the key driving factors for the growth of the sector in the country. The ‘Pharma Vision 2020', introduced to make India a global leader in end-to-end drug manufacturing, has also boosted investments. To know more
about the event and register for a free entry to the event, visit - www.ubmindia.in/pharmalytica
About UBM Asia UBM Asia recently became part of Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Please visit www.ubm.com/asia for more information about our presence in Asia.
About PharmaLytica: PharmaLytica is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world. Please visit www.ubm.com/india for more information about our presence in India. Important News UBM Asia has joined Informa Markets, a business dedicated to help specialist markets and customer communities around the world to trade, innovate and grow through exhibitions and digital content and services. Through our brand is changing, our commitment to the success of customers and partners remain strong.
Business News
Telstar launches a new website and consolidates its digital communication strategy Terrassa (Barcelona) 2019, May 13th. Telstar has renewed the design and architecture of its website. With a web-portal adapted to an operational and practical format, the new website consolidates the company’s strategy in the field of digital communication. The new website keeps the address www.telstar.com. The completely revamped website offers a modern visual approach and a streamlined design. It features a simplified design, improved functionality and enriched content areas, all of this enhanced with technology-based knowledge resources in the field of aseptic and efficient production of pharmaceutical and biotechnology processes, vacuum & high-vacuum solutions, critical process facilities and clean rooms, integrated process systems, process analytical technologies, among others. The new platform includes new features to help users to quickly and easily navigate and find the solution they need. Besides offering a responsive design, the website provides a clean, fresh layout by a modern look that makes easier to read and search, accessibility that enables effortless access to all content, and efficient search ability since the distribution of sections and key words enables an easy search process. Just as the new website includes more visual elements under user-friendly formats, the company has also provided further ways of interaction and engagement with the audience through the inclusion of specific windows of contact appearing in each of the pages. The new portal-web is accessible to all web devices, from desktop computers to portables, tablets and smartphones, and compatible with all readable formats. Structure focused on solutions
Telstar’s capacity to develop global and complete solutions in design, engineering, construction and process equipment & technology, including turnkey projects and critical installations, leads the company to offer a wide comprehensive portfolio of products and services. One of the more complex challenges was to be able to accommodate this multidisciplinary and broad activity on a visual and effective content distribution and a simplified structure design of the website under a user-friendly interface. To achieve an easy navigation and maximum performance in search processes, the new portal features clear menus, simple tabbed sections and live links. The home page offers two main menus: a specific tab for corporate information and another menu bar that provides information related to Telstar’s products & services in the field of engineering & projects (engineering, construction, GMP consultancy and GMP management software & digitalization) and pharma process equipment (barrier systems, sterilization and freeze-drying systems, including PAT technologies). This menu is completed with lab equipment, vacuum equipment and a highvalued support services sections. The corporate menu bar also includes specific sections intended to offer information related to different subsidiaries, technology centers and offices that the company has globally, as well as references related to relevant projects developed by the company. Within the news section, the audience can access to a consistent offer of technically based white papers produced by Telstar’s specialized professional team, as well as keeping up-to-date on new projects, innovations and latest developments carried out by Telstar.
For more information: TELSTAR Phone: +34 93 736 16 00 Website: www.telstar.com E-mail:pr@telstar.com
Microbioz India, June 2019
25
Business News
Granules India limited received US FDA approval for Acetaminophen 650 mg, Extended Release Tablets Granules India Ltd., announced that the US FDA has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen 650 mg Tablets, Extended Release, bioequivalent to the reference listed drug product (RLD), Tylenol 650mg tablets, Extended Release. Acetaminophen 650 mg extended release tablets are used primarily for temporary pain management including arthritis relief “The addition of Acetaminophen 650mg, extended release tablets to our OTC portfolio leverages several components of our value proposition. Granules’ is the only supplier that is backward integrated up to the API on this product. Our vertically integrated approach will enable us to provide a high-quality, cost-efficient product that benefit consumers. With a capacity of over 24,000 mt/year of Acetaminophen API and finished dosage capacity of more than 18 billion units/year, we are confident that we will ensure supply security to our customers which will support us to capture our target market share,” said Mr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India. About Granules India Ltd. (BSE: 532482, NSE: GRANULES)
Granules India is a growing pharmaceutical manufacturing company with best in class facilities and is committed to operational excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) which gives the customers flexibility and choice. Granules support customers with unique value, extensive product range, and proactive solutions. The Company’s global presence extends to over 250 customers in 60 countries through offices in India, U.S., and U.K. The Company has 8 manufacturing facilities out of which 6 are located in India, 1 in China and 1 in USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC and HALAL.
For further information please contacts: Sumanta Bajpayee Head - Corporate Finance & Investor Relations 040-30663572 sumanta.bajpayee@granulesindia.com Chaitanya Tummala Company Secretary 040-30663614 chaitanya.tummala@granulesindia.com
Microbioz India, June 2019
26
Research News
New compound which kills antibioticresistant superbugs discovered A new compound which visualises and kills antibiotic resistant superbugs has been discovered by scientists at the University of Sheffield and Rutherford Appleton Laboratory (RAL). The team, led by Professor Jim Thomas, from the University of Sheffield's Department of Chemistry, is testing new compounds developed by his PhD student Kirsty Smitten on antibiotic resistant gramnegative bacteria, including pathogenic E. coli.Gramnegative bacteria strains can cause infections including pneumonia, urinary tract infections and bloodstream infections. They are difficult to treat as the cell wall of the Bacterial culture (stock image). bacteria prevents drugs from Credit: Š motorolka / Adobe Stock getting into the microbe. several gram-negative bacteria at the top of its list, Antimicrobial resistance is already responsible for stating that new treatments for these bacteria were 25,000 deaths in the EU each year, and unless this 'Priority 1 Critical' because they cause infections rapidly emerging threat is addressed, it's estimated with high death rates, are rapidly becoming by 2050 more than 10 million people could die resistant to all present treatments and are often every year due to antibiotic resistant infections. picked up in hospitals. Doctors have not had a new treatment for gramThe research, published in the journal ACS Nano, negative bacteria in the last 50 years, and no describes the new compound which kills grampotential drugs have entered clinical trials since negative E. coli, including a multidrug resistant 2010. pathogen said to be responsible for millions of The new drug compound has a range of exciting antibiotic resistant infections worldwide annually. opportunities. As Professor Jim Thomas explains: Note: The story is for information purposes for "As the compound is luminescent it glows when more information follow original story source. exposed to light. This means the uptake and effect Story Source and credit:Science daily on bacteria can be followed by the advanced Journal Reference: microscope techniques available at RAL. Kirsty L. Smitten, Hannah M. Southam, Jorge "This breakthrough could lead to vital new Bernardino de la Serna, Martin R. Gill, Paul J. treatments to life-threatening superbugs and the Jarman, Carl G. W. Smythe, Robert K. Poole, Jim growing risk posed by antimicrobial resistance." A. Thomas. Using Nanoscopy To Probe the The studies at Sheffield and RAL have shown the Biological Activity of Antimicrobial Leads That compound seems to have several modes of action, Display Potent Activity against Pathogenic, making it more difficult for resistance to emerge Multidrug Resistant, Gram-Negative in the bacteria. The next step of the research will Bacteria . ACS Nano , 2019; 13 (5): 5133 be to test it against other multi-resistant bacteria. DOI: 10.1021/acsnano.8b08440 In a recent report on antimicrobial resistant pathogens, the World Health Organisation put
Microbioz India, June 2019
28
Product Launch
Freeze-Drying Microscope Generates Critical Formulation Specific Data SP Scientific has video interviewed Dr Kevin Ward of Biopharma Process Systems Ltd, to discuss the key benefits of the Lyostat5 FreezeDrying Microscope (FDM), and how it can be used to generate critical formulation-specific data Every freeze-drying formulation has a critical temperature, below which it should be maintained during primary drying in order to prevent processing defects.
Dr Ward explains how using the Lyostat5 freeze drying microscope allows observation of the sample structure during drying and precise temperature control when cooling or heating so that the exact point of collapse can be determined. In addition, he describes how the Lyostat5 freezedrying microscope lighting and image capture systems provide sharp visualisation for easy, accurate identification of structural changes. Using the derived data, he explains how after analysis has been carried out that formulations and cycles can be developed that are safe, robust, and cost efficient. Dr Ward summarises that for every 1°C higher a formulation can be freeze dried at, then results in an efficiency saving of 13%.
The Lyostat5 freeze drying microscope is part of the SP Scientific Line of Sight™- enabled suite of freeze drying equipment and technologies portfolio. As well as enabling the determination of critical temperatures including eutectic melting temperature (Teu) and collapse temperature (Tc), the Lyostat5 freeze drying microscope also
enables the identification of crystallization phenomena, skin/crust formation, and the effects of annealing on ice crystal growth and solute structure. Knowledge of the critical temperatures is essential to conduct cycle development on a rational, quantitative scientific basis as well as saving precious resources in terms of time and monies needed. The Lyostat5 freeze-drying microscope is supplied fully validated as a complete working system against a series of standard solutions. For further information on the Lyostat5 freeze drying microscope, please contact SP Scientific on +1-845-255-5000 (+44-1473-240000 in Europe). Story source / Credit: SP Scientific Inc
M926 Chloride Analyser and Active Salt Software Package from Sherwood Scientific M926 Chloride Analyser and Active Salt Software Package from Sherwood Scientific makes QA/QC checks for Salt in Processed Foods, Dairy Products and Snacks Simpler.
For many years Sherwood Scientific’s Model 926 Chloride Analyser has been used for salt measurement by food ingredient suppliers and food manufacturers throughout the world. The M926 offers many benefits over other methods for Chloride determination. Simplicity, speed, and accuracy, are all important and well established with no requirement to make reagents. Cost per test has of course always been of interest but increasingly the cost of post-test reagent disposal is also an important consideration when deciding which method of salt determination to use. The coulometric titration
Microbioz India, June 2019
30
Product Launch performed by the 926 with silver ions generated in situ is ideal for keeping those costs down; helping to further cement the Model 926’s reputation as an industry leader. The Model 926 is particularly popular within the processed foods industry for QA/QC checks on final product salt content. Briefly; the analysis of salt content, including sample preparation, goes as follows;
Weigh sample; add warm water, macerate to dilute and dissolve salt present, filter, standardise extract volume and finally pipette the extract into the chloride analyser’s beaker and press titrate. The chloride result, together with sample and diluent weights, are used to calculate the salt content of the original foodstuff or ingredient. Cheese, Butter, Whey Protein Concentrate, Cream for the dairy industry, whilst all manner of savoury snacks and processed foods can be evaluated. Sherwood Scientific’s Active Salt software package simplifies that process. Using RS232 outputs from the Model 926 Chloride Analyser and also a weighing balance; data is transferred and collected without manual transcription.
The Salt content calculation is performed immediately all three data values have been collected and the result for the sample under test displayed for instant feedback. All results may be reported once a complete batch of samples has been analysed. The software offers improved efficiency and reduction of errors. It also allows setting of upper and lower limits for salt content of a given product line. Samples with results outside the limits are instantly highlighted, allowing corrective. Active Salt software can take data from two Model 926 Chloride analysers and two balances connected to one PC and may be used to simplify the salt content calculation for both food and food ingredients. Story source / Credit: Sherwood Scientific Ltd
Thermo Scientific SureTect Real-Time PCR Pathogen Detection System provides an easy-to-use workflow for rapid, accurate pathogen detection Extended validation scope means more streamlined rapid pathogen testing for foodtesting laboratories. Thermo Scientific SureTect PCR Assays are now validated to run on the Applied Biosystems SimpliAmp Thermal Cycler and Applied Biosystems QuantStudio 5 Food Safety System, which means a streamlined workflow that requires
fewer touchpoints. Laboratories can now work more efficiently and release products quickly and confidently when helping to safeguard the world's food. AOAC PTM and NF VALIDATION certification covers SureTect Assay workflows for the detection of Salmonella species, Listeria species, Listeria monocytogenes, Escherichia coli O157:H7 and Cronobacter species (NF VALIDATION certification only) in a variety of foods and production environment samples. Heating steps for the SureTect Assay sample preparation process are now fully automated using the SimpliAmp Thermal Cycler, taking just 25 minutes to prepare sample lysates ready for PCR. The SimpliAmp touchscreen interface makes it easy to set up and save the parameters required for SureTect Assays and other applications. When needed, the required program can be recalled and ready to use in seconds. The Applied Biosystems QuantStudio 5 Food Safety Instrument is a high-performance benchtop platform that gives users greater control of data and combines out-of-the box installation, ease-of-
Microbioz India, June 2019
32
Product Launch use and system connectivity with powerful options to enable maximum control. The 6-channel, 96well, cloud-enabled open platform is suitable for running the full range of PCR solutions for food safety, authenticity and quality testing. Combining the QuantStudio 5 Food Safety Instrument with user-friendly Thermo Scientific RapidFinder Analysis software makes SureTect test set-up, running and automatic result interpretation simple and helps avoid errors and subjective result determination. "This year we are not only extending the validation scope with simplified workflows and access to powerful new instruments, but also expanding the range of SureTect Assays with new kits for additional foodborne pathogen targets important to our customers," said Bernd Hofmann, vice president, marketing, Thermo Fisher Scientific. "We continue to invest in our mission to enable our customers to make the world safer by simplifying food pathogen testing to deliver speed, accuracy and reliability of results. We expect the new SureTect Assays to launch in the second half of the year." Validation studies to certify the SureTect Assays with the new instrumentation will match the current scope of AOAC-RI and NF VALIDATION certified workflows with the Applied Biosystems 7500 Fast Food Safety System covering an extensive range of food and production environment sample types. In addition, a 375 g milk powders and ingredients category will be added to the SureTect Salmonella species Assay range of NF VALIDATION claims as well as adding the fruits and vegetables category to the SureTect E coli O157:H7 Assay claims. The new SureTect Assay workflows will follow the same parameters of those already available, including: Single enrichment protocols for faster time-to-result and streamlined workflow Pre-dispensed reagents, reducing handling steps and risk of operational error Universal PCR protocols for detecting multiple targets in the same run User-friendly RapidFinder Analysis software for simple set-up and avoidance of subjective interpretation Story source / Credit: Thermo Fisher Scientific
Glass Bottom Microplates for Imaging Applications The family of ultra-flat Krystal™ glass bottom microplates from Porvair Sciences provide unmatched performance for high-throughput screening and tissue culture applications.
The automation-compatible Krystal™ plates combine the advantageous optical properties of glass, low background and low birefringence, with the versatility of a microplate. Precision engineered, using a polystyrene frame and a borosilicate glass sheet fixed to the base with a biocompatible adhesive, Krystal™ plates offer a high degree of planar flatness (+/- 50 microns) across the base, excellent light transmission and a flat optical plane for growing cells. In addition, the nominal cut-off wavelength of 335nm allows most fluorescence assays to be excited or read through the plate glass bottom. These unique advantages together also translate into a significant increase in measurement precision and elimination of read errors when performing cell-based assays using fluorescent or luminescent imaging. Krystal™ glass bottom plates are proven to demonstrate higher performance than standard polystyrene plates for whole plate CCD imaging, laser detection and high-resolution microscopy using confocal imaging. Available in a choice of ANSI/SLAS standard 96- and 384-well formats. Story source / Credit: Porvair Sciences Limited
Microbioz India, June 2019
33
Product Launch
Gilson announce the release of the extended mass range VERITY® 1910 MS Detector
The VERITY 1910 MS Detector can be combined with a PLC Purification System or with any Gilson VERITY HPLC system. When bundled with a VERITY purification system, it provides an outof-the-box, ready solution for mass-directed purification.
Mass spectrometry (MS) technology has become an essential tool in the purification field. Once viewed as a complex and expensive process requiring highly specialized technicians to operate, the VERITY 1910 MS Detector makes MS detection simple and affordable for any preparative purification system.
• Easy to use, simple, “plug and play” consumables
The VERITY® 1910 MS Detector is a unique, chip-based mass detector that can be integrated into purification systems for HPLC, flash chromatography, or centrifugal partition chromatography (CPC). It increases laboratory efficiency and reduces the overall cost of ownership while providing reliable and highly accurate MS data for the scientist in a more comfortable laboratory environment. Having chip-based technology, the VERITY 1910 reduces the size and maintenance costs associated with a conventional single quadrupole MS detector, such as changing roughing pump oil. The VERITY 1910 MS Detector improves the overall laboratory environment with ultra-quiet operation and low heat generation.
• Small footprint enables deployment anywhere within laboratory or processing facilities • Fully integrated system, with no external vacuum pumps
• Single quadrupole with a mass range of 50-1400 m/z Story source / Credit: Gilson UK
Chromatography in Cannabis Testing | Greyhound Chromatography Chromatography is one of the most popular methods to test whether cannabis is safe for use or not. This has become an important part of the cannabis industry and the many new regulations that come with it. To ensure the health and wellbeing of consumers, chromatography is undergoing a major overhaul. The cannabis industry is growing exponentially thanks to the legalization of medicinal and recreational cannabis in many places around the world. Take the US, for example, where a growing legion of states have fully legalized both forms of cannabis. Canada has upped the ante further by enacting countrywide legalization of cannabis beginning in lateOctober 2018. As a result, individual states and provinces are mandating that all cannabis products adhere to certain regulations and are tested to assure consumers of their safety. Many of these regulations require growers to test their plants for any signs of pesticide, solvent, and heavy metal contamination. Testing the intensity of cannabinoid
Microbioz India, June 2019
34
Product Launch potency is also a serious step required by regulations. This ensures that the tetrahydrocannabinol (THC) and can
Compact and with no moving parts, the highly reliable Flow-UV™ fits conveniently into even crowded fume cupboards and does not require calibration routine servicing. In contrast to conventional Deuterium lamps, the Flow-UV™ uses a Xenon flash lamp source which has a lifetime of up to 10 years in normal use. Fibre optic
nabidiol (CBD) levels are under certain thresholds and do not exceed the stipulated standards. THC is the cannabinoid responsible for cannabis’ psychedelic effects, while cannabidiol boasts other beneficial features. Growing Demand Requires Higher Testing Standards With this in mind, how are these tests actually done? Well, there are a number of testing methods, but one of the best and most popular is chromatography. Story source / Chromatography Ltd
Credit:
Greyhound
Flow Detector Monitors Dispersion in Real Time Uniqsis reports on how its Flow-UV™ inline UVVisible spectrometer sets a new benchmark for real-time dispersion and nanoparticle distribution and agglomeration experiments. Designed for use with almost any commercially available flow chemistry system, Flow-UV™ allows dispersion experiments to be monitored in real time so that product collection can be controlled according to the onset and decline of steady-state conditions. It also provides a useful indication that steady state is maintained consistently throughout a continuous flow-through process. UV-Visible measurements can also be particularly significant for nanoparticle distribution and provide information about particle size and whether agglomeration is occurring.
waveguides connect the Flow-UV™ flow cell to the source and detector thereby permitting the flow cell to be positioned virtually anywhere in the flow path. The flow cell itself utilises a short length of PFA reactor tubing and is therefore not restricted to being located after the outlet back pressure regulator in the low-pressure region of the flow path where outgassing can be problematic.
Flow-UV™ has been designed to be extremely easy to use. To assure linearity of response, Flow-UV™ offers users the ability to select up to five wavelengths over which to monitor a reaction, so helping to avoid detector saturation. Absorbance is plotted against time using the system control software. The control software can be configured to automatically record a background spectrum at the beginning of each experiment. Having previously set up and saved a method, pressing a single button is all that is required to start acquisition.
Story source / Credit: Uniqsis Ltd
Microbioz India, June 2019
36
Product Launch
Reinforce rubber inflated seal by Amipolymer Pvt Ltd A pneumatic inflatable gasket seal is technological advancement in the arena of rubber technology in recent decades. An inflatable seal is a fabricreinforced elastomeric tube that is molded in a concave, convoluted or flat configuration. It is designed in such a way that it is inflated pneumatically and form a tight barrier between a mounting and striking surface. For example, see the cross section illustration below. Position A shows the molded configuration and Position B depicts the inflated configuration.
Upon introduction of air, Gasket or seal immediately inflated and exposed to striking surface. It now works as positive seal. When inflated medium is removed then the seal retract naturally to the deflated mold configuration. This arrangement gives free movement of one or both surface. Most of common inflation media is air that is pneumatic process. Optimum pressure is determined by end uses. Sometime liquids and gels are also used. Introduction of inflatable media through a stem which is a flexible hose secured a integrally mold fittings.
Figure 1Schematics of Fabric reinforced rubber gasket
Figure 2 A
Figure 3some cross sections of inflatable gasket
Microbioz India, June 2019
38
Product Launch
Inflatable sealing with reinforcement having certain advantages. First of all it gives leak-proof closure and provides space when needed. It minimize fabricating tolerance and simplifies the structures. Under compression it does not give any negate effect.
Life cycle is higher for such a reinforced gasket compared to unreinforced one. By: PritamAdhikary (Executive-R&D) Ami Polymer Pvt. Ltd. # +91 82389 22236 research@amipolymer.com
Product Launch
Microfluidizer Offers Effective Cell Disruption Analytik reports on how the School of Biological & Chemical Sciences at Queen Mary University, London (QMUL) has been using a LM20 Microfluidizer for cell disruption of a broad range of cell types including E. coli, Yeasts and Diatom. The School of Biological and Chemical Sciences at QMUL is one of the UK’s leading life science research departments, with a multi-disciplinary approach to teaching and research. QMUL research staff are actively engaged in a wide range of projects across the broad sweep of biological, chemical and psychological sciences. Petra Ungerer, Cell and Molecular Biology Laboratories Manager at QMUL commented ‘We approached Analytik to find a replacement for a high-pressure homogeniser, from another manufacturer, which had been unreliable and failed to achieve sufficient lysis of our tough yeast cells even after very many passes. We selected the LM20 Microfluidizer not only because it efficiently lysed a broad range of cell types but also was incredibly simple and easy to use which is very important as many different people need to use the machine regularly”. Dr Ungerer added “We also much appreciate the knowledgeable technical and applications support provided by Analytik which has enabled us to fully exploit the considerable capabilities of the LM20 Microfluidizer”. The LM20 Microfluidizer is a digitally controlled high pressure homogeniser performance optimised for small volumes. It maintains identical sample processing conditions, reliably producing the desired results, including uniform particle and droplet size reduction (often submicron), deagglomeration and high-yield cell disruption. Ian Laidlaw, Managing Director of Analytik commented "We were very pleased to have been
selected by QMUL to supply a high-pressure homogeniser for their broad ranging cell disruption needs. In our experience it is now not necessary for biological scientists to accept limitations on the cell types that they can reliably and efficiently disrupt. Our LM20 Microfluidizer uniquely combines top performance, operational
efficiency and ease of use for this important application”. For over 15 years - Analytik has been a trusted supplier of cutting-edge scientific instrumentation to leading organisations throughout the UK and Ireland. In addition to supplying innovative analytical instrumentation from global technology providers, we deliver added value through specialised consultative expertise and comprehensive pre and post-sales support to ensure that our customers get the most out of their investment. For further more detailed information on the LM20 Microfluidizer please contact Analytik on +44-1954-232776.
Story source / Credit: Analytik Ltd
Microbioz India, June 2019
40
Product Launch
New MM 500 Mixer Mill from Retsch UK The new MM 500 Mixer Mill from Retsch is a compact, versatile bench-top unit which has been developed for dry, wet and cryogenic grinding of small sample amounts.
The MM 500 Mixer Mill will mix and homogenize powders in only a few seconds, is simple to use and is the perfect combination of a classic mixer mill and a planetary ball mill. Retsch Mixer Mills are true allrounders which are used in laboratories all over the world. For heavy milling over several hours where high energy input is required to obtain particles sizes < 1 µm, (eg. for mechanical alloying or chemical reactions), planetary ball mills have to date been the preferred solution. Despite their benefits for this type of application, they have a major drawback as cooling breaks are required during processing and they are not as easy to handle as mixer mills. The new MM 500 Mixer Mill features a maximum frequency of 35Hz. It is the first mixer mill on the market which delivers the crushing power required to produce particles in the nanometer range. Accommodating 2 grinding jars sized 50 ml, 80 ml or 125 ml with an ability to run continually for up to 99 hours and to take interim samples in situ without removal of the jars, the MM 500 a real alternative to planetary ball mills where breaks in processing are required to avoid sample heating.
Benefits at a glance:
Grind sizes < 100nm Easy handling of jars and clamping system Grinding jar volumes 50ml, 80ml & 125ml Screw-Lock jars, pressure-tight up to 5 bar 4 grinding jar materials: stainless steel, hardened steel, zirconium oxide & tungsten carbide 3 different grinding modes (dry, wet or cryogenic) Jars may stay clamped while taking a subsample or checking the particle size Suitable for long-term grinding up to 99 hours, usually without cooling breaks Ensures quick pulverization of sample materials like MM 400 (if one large ball is used) Memory for 12 SOPs and 4 program cycles Can be controlled via the optional RETSCH App Modern design, touch display
Call Retsch today on 0845 458 5196 for a demonstration of the MM 500 Mixer Mill
Story source / Credit: Retsch UK
Powerful grinding with a maximum frequency of 35Hz
Microbioz India, June 2019
42
Product Launch
Agar Scientific launches uranium-free UAZero® EM Stain Agar Scientific has unveiled the latest addition to its range of microscopy stains, UA-Zero® EM Stain, a non-radioactive alternative to the traditional Uranyl Acetate. UA-Zero is a direct replacement for Uranyl Acetate, offering comparable results from the same standard processes, while simultaneou sly eliminating the safety and logistical issues associated with stains derived from uranium. For decades, electron microscopists worldwide have relied on Uranyl Acetate solution for staining biological samples, however, it can be hard to obtain and is subject to stringent and restrictive regulations – as well as additional costs – when it comes to transportation, use and disposal. UAZero is a new, efficient, non-toxic, uranium-free alternative that delivers comparable results to Uranyl Acetate, and can be directly substituted into existing laboratory protocols. In contrast to uranyl acetate, it does not require specialist handling and disposal, and can be exported worldwide without the logistical problems of the past.
Paul Balas, Technical Director at Agar Scientific said: “Microscopists have long sought a non-toxic, uranium-free alternative to uranyl acetate, and we are delighted to be able to meet this need. We are
sure UA-Zero will have a huge impact in the field, and look forward to supplying it to customers, old and new.” Story source/ credit: Agar Scientific Ltd
Microbioz India, June 2019
44
PUBLISHED ON: 5th June 2019 RNI NUMBER: UPENG/2017/73675